MARKET

LPCN

LPCN

Lipocine
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.4150
-0.0060
-1.43%
Closed 16:00 04/03 EDT
OPEN
0.4300
PREV CLOSE
0.4210
HIGH
0.4300
LOW
0.4050
VOLUME
252.61K
TURNOVER
--
52 WEEK HIGH
3.450
52 WEEK LOW
0.3010
MARKET CAP
19.86M
P/E (TTM)
-0.8174
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average LPCN stock price target is 3.500 with a high estimate of 5.00 and a low estimate of 2.000.

EPS

LPCN News

More
  • Lipocine Announces Outcome of Markman Hearing in Patent Infringement Suit Against Clarus
  • PR Newswire · 03/26 13:00
  • Lipocine Announces 2019 Year End Financial and Operational Results
  • PR Newswire · 03/13 13:00
  • Lipocine Q4 EPS $(0.5) Up From $(0.55) YoY
  • Benzinga · 03/13 12:05
  • Lipocine Announces TLANDO™ PDUFA Date of August 28, 2020
  • PR Newswire · 03/04 13:00

Industry

Biotechnology & Medical Research
-0.50%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About LPCN

Lipocine Inc. is a specialty pharmaceutical company. The Company is focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men's and women's health. Its primary development programs are based on oral delivery solutions for bioavailable drugs. Its lead product candidate, LPCN 1021, is an oral testosterone replacement therapy (TRT), designed for twice-a-day dosing and is in Phase III testing. The Company's additional pipeline candidates include LPCN 1111, an oral testosterone therapy product targeted for once daily dosing, which is in Phase II testing, and LPCN 1107, an oral therapy for the prevention of preterm birth, which is in Phase I testing. These products are based on its Lip'ral promicellar drug delivery technology platform. Lip'ral promicellar technology is a technology based on lipidic compositions, which form an optimal dispersed phase in the gastrointestinal environment for improved absorption of insoluble drugs.
More

Webull offers kinds of Lipocine Inc stock information, including NASDAQ:LPCN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LPCN stock news, and many more online research tools to help you make informed decisions.